09:00
Main Programme.
23 November 2020
Henry Cheng International Conference Centre, CUHK campus, Hong Kong
Lecture Theatre 1A
Lecture Theatre 1B
- 09:00
- 09:10
- 09:20
- 09:30
- 09:40
- 09:50
- 10:00
- 10:10
- 10:20
- 10:30
- 10:40
- 10:50
- 11:00
- 11:10
- 11:20
- 11:30
- 11:40
- 11:50
- 12:00
- 12:10
- 12:20
- 12:30
- 12:40
- 12:50
- 13:00
- 13:10
- 13:20
- 13:30
- 13:40
- 13:50
- 14:00
- 14:10
- 14:20
- 14:30
- 14:40
- 14:50
- 15:00
- 15:10
- 15:20
- 15:30
- 15:40
- 15:50
- 16:00
- 16:10
- 16:20
- 16:30
Lecture Theatre 1A
-
09:00-10:3009:00What is New in Irritable Bowel SyndromeLecture Theatre 1AWhat is New in Irritable Bowel Syndrome09:00-09:30Low FODMAP Diet and IBSVictoria Tan (Hong Kong)09:30-10:00Use of Probiotics in IBDJustin WUThe Chinese University of Hong Kong
- Professor of Gastroenterology
CUHK Medical Centre- Chief Operating Officer
10:00-10:30New Pharmacological Treatment in IBSKewin SIAHNational University Hospital, Singapore- Gastroenterology Consultant
10:30-11:0011:00-12:3011:00IBD in Resource-limited SettingLecture Theatre 1AIBD in Resource-limited SettingChair: Rupa BANERJEE and Siew NG11:00-11:30Optimizing Clinical Use of Mesalazine in the Treatment of IBDByong-duk Ye (South Korea)11:30-12:00IBD in Resource-limited Countries: Challenges in DiagnosisRupa Banerjee (India)12:00-12:30IBD in Resource-limited Countries: Challenges in ManagementShu-chen Wei (Taiwan)12:30-13:2013:20-14:5013:20Lunch Symposium (C): Immunotherapy of GI and Liver CancerLecture Theatre 1ALunch Symposium (C): Immunotherapy of GI and Liver CancerChair: Rashid LUI13:20-13:50Updates on Colorectal Cancer ImmunotherapyBrigette Ma (Hong Kong)13:50-14:20New Advances in Liver Cancer ImmunotherapyStephen CHANThe Chinese University of Hong Kong- Associate (Clinical) Professor, Department of Clinical Oncology
14:20-14:50Troubleshooting of Cancer ImmunotherapyRashid LUIPrince of Wales Hospital- Associate Consultant, Department of Medicine and Therapeutics
The Chinese University of Hong Kong- Clinical Assistant Professor (Honorary), Department of Medicine and Therapeutics
14:50-16:2014:50HBV Management in 2020Lecture Theatre 1AHBV Management in 2020Chair: Vincent WONG14:50-15:20HCC Risk Reduction by NA – Is One NA Better than the OtherGrace WONGThe Chinese University of Hong Kong- Professor, Institute of Digestive Disease
- Professor, Department of Medicine and Therapeutics
- Professor, State Key Laboratory of Digestive Diseases (CUHK)
- Assistant Dean (Learning Experience), Faculty of Medicine
15:20-15:50Functional Cure of HBV – Are We Getting Close?Alexander THOMPSONUniversity of Melbourne, Australia- Professor, Department of Gastroenterology
St. Vincent's Hospital, Australia- Director, Department of Gastroenterology
The National Health and Medical Research Council, Australia- Practitioner Fellow
Duke University Medical Center, USA- Adjunct Assistant Professor, Department of Gastroenterology
15:50-16:20Why Do We Still Need HCC Risk Score?Henry CHANThe Chinese University of Hong Kong- Professor and former director, Institute of Digestive Disease
- Director, Center for Liver Health
- Associate Dean (External Affairs), Faculty of Medicine
- Director, Office of Global Engagement, Faculty of Medicine
- Associate Head, Shaw College
Lecture Theatre 1B-
09:00-10:3009:00GUT-IDDF Young Investigator Award: Oral Presentation ILecture Theatre 1BGUT-IDDF Young Investigator Award: Oral Presentation I10:30-11:0011:00-12:3011:00GUT-IDDF Young Investigator Award: Oral Presentation IILecture Theatre 1BGUT-IDDF Young Investigator Award: Oral Presentation II12:30-13:2014:50-16:3014:50JGH-IDDF Case/Video Champion: Oral PresentationLecture Theatre 1BJGH-IDDF Case/Video Champion: Oral Presentation14:50-16:30
What is New in Irritable Bowel SyndromeGUT-IDDF Young Investigator Award: Oral Presentation IType : Main Programme Venue : Lecture Theatre 1B, Henry Cheng International Conference Centre, CUHK campus, Hong Kong 09:00GUT-IDDF Young Investigator Award: Oral Presentation IIBD in Resource-limited SettingType : Main Programme Venue : Lecture Theatre 1A, Henry Cheng International Conference Centre, CUHK campus, Hong Kong Chair : Rupa BANERJEE and Siew NG 11:00Optimizing Clinical Use of Mesalazine in the Treatment of IBD11:30IBD in Resource-limited Countries: Challenges in Diagnosis12:00IBD in Resource-limited Countries: Challenges in ManagementGUT-IDDF Young Investigator Award: Oral Presentation IIType : Main Programme Venue : Lecture Theatre 1B, Henry Cheng International Conference Centre, CUHK campus, Hong Kong 11:00GUT-IDDF Young Investigator Award: Oral Presentation IILunch Symposium (C): Immunotherapy of GI and Liver CancerType : Main Programme Venue : Lecture Theatre 1A, Henry Cheng International Conference Centre, CUHK campus, Hong Kong Chair : Rashid LUI HBV Management in 2020Type : Main Programme Venue : Lecture Theatre 1A, Henry Cheng International Conference Centre, CUHK campus, Hong Kong Chair : Vincent WONG JGH-IDDF Case/Video Champion: Oral PresentationType : Main Programme Venue : Lecture Theatre 1B, Henry Cheng International Conference Centre, CUHK campus, Hong Kong 14:50JGH-IDDF Case/Video Champion: Oral Presentation